Skip to main content

Novo Nordisk Fellowships

Missing ALT text.

Novo Nordisk Postdoctoral Fellowship Programme at Karolinska Institutet

This fellowship programme aims to support the development of a new generation of exceptional young diabetes and metabolism researchers, to become future leaders in the field, while further developing scientific excellence within these areas ultimately improving the lives of patients.

Call for postdoc applications 2019 - Now closed!

The Novo Nordisk Postdoctoral Fellowship Programme at KI was initiated in 2015 and has completed four rounds of recruitments and we have to date appointed 16 postdoctoral fellows. This call is, thus, our fifth round of recruitment of 4 postdoctoral fellows for an expected start date in the autumn of 2019. Deadline for applications - Sunday 7 April, 2019.


Based at Karolinska Institutet, Fellows will undertake cutting edge research projects, mentored by front-line researchers in the field of diabetes and metabolism. In addition, it is anticipated that during the course of the fellowships, fellows will have the opportunity to spend approximately 3 months in the research laboratories at Novo Nordisk in Copenhagen. Thus, Fellows will gain insight into research conducted in both academia and industry. In order to increase coherence around the Fellowship programme, a number of events will be held throughout the year such as high profile lectures, symposia, etc. which the fellows will attend, both at Karolinska Institutet and at Novo Nordisk in Copenhagen.

  • The postdoctoral research fellowships are aimed at early career researchers with a basic science background.
  • Fellowships are fully funded for a 3-year period providing salary as well as travel allowance for the fellow.
  • The fellowship programme is open to outstanding candidates of any nationality.

Workshops and meetings

Earlier Novo Nordisk-KI workshops:

Programme from workshop September 27, 2018 can be downloaded here

Programme from workshop October 11, 2017 can be downloaded here

Programme from workshop November 10, 2016 can be downloaded here

Current fellows

Dr Isabel Cordero Herrera

Principal Investigator: Assoc Prof Mattias Carlström, Renal and Cardiovascular Research, Dept of Physiology and Pharmacology


Dr Lucile Dollet

Principal Investigators: Prof Anna Krook and Prof Juleen Zierath, Section of Integrative Physiology, Dept of Physiology and Pharmacology


Dr Thomas Ebert

Principal Investigators: Prof Peter Stenvinkel and Prof Annika Wernerson, Dept of Clinical Science, Intervention and Technology


Dr Sanna Hellberg

Principal Investigators: Assoc Prof Stephen Malin and Prof Göran K Hansson, Cardiovascular Research, Dept of Medicine Solna


Dr Alastair Kerr

Principal Investigator: Assoc Prof Ingrid Dahlman, Lipid Laboratory, Dept of Medicine Huddinge


Dr Kelvin Kwok

Principal Investigator: Assoc Prof Carsten Daub, Prof Mikael Rydén and Prof Peter Arner, Dept of Medicine Huddinge


Dr Noah Moruzzi

Principal Investigator: Assoc Prof Ingo Leibiger, Insulin Receptor Signalling, Dept of Molecular Medicine and Surgery


Dr Lars Paeger

Principal Investigator: Assoc Prof Christian Broberger, Dept of Neuroscience


Dr Vladimir Shavva

Principal Investigator: Prof Peder Olofsson, Dept of Medicine, Solna


Dr Daniel Svensson

Principal Investigators: Assoc Prof Hjalmar Brismar and Prof Anita Aperia, Pediatric cell and molecular biology, Dept of Women’s and Children’s Health



Dr Pauline Vercruysse

Dr Ester Bachar-Wikström

Dr Soile Tuomela

Dr Lars Ketscher

Dr Montserrat Visa

Dr Nicole Schmitner

Programme Steering Committee

Karolinska Institutet members

Prof. Juleen Zierath, Clinical Physiology. Steering Committee Chairman

Prof. Anders Gustafsson, Dean of Research

Prof. Nancy Pedersen, Medical Epidemiology

Prof. Barbara Canlon, Hearing Physiology

Novo Nordisk members

Dr. Peter Kurtzhals, Chief Scientific Advisor, Novo Nordisk R&D

Dr. Martin Ridderstråle, Corporate Vice President, Clinical Pharmacology & Translational Medicine

Dr. Mads Tang-Christensen, Corporate Vice President, Obesity Research



Programme Manager

Håkan Karlsson